Log in

Relevant bibliographies by topics / HIV+ Persons / Journal articles

To see the other types of publications on this topic, follow the link: HIV+ Persons.

Journal articles on the topic 'HIV+ Persons'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'HIV+ Persons.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Bosh, K. A., J. R. Coyle, V. Hansen, et al. "HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities." Epidemiology and Infection 146, no. 7 (2018): 920–30. http://dx.doi.org/10.1017/s0950268818000766.

Full text

Abstract:

AbstractCoinfection with human immunodeficiency virus (HIV) and viral hepatitis is associated with high morbidity and mortality in the absence of clinical management, making identification of these cases crucial. We examined characteristics of HIV and viral hepatitis coinfections by using surveillance data from 15 US states and two cities. Each jurisdiction used an automated deterministic matching method to link surveillance data for persons with reported acute and chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections, to persons reported with HIV infection. Of the 504 398 pers

APA, Harvard, Vancouver, ISO, and other styles

2

Kartashov, Mikhail Yu, Kirill A. Svirin, Ekaterina I. Krivosheina, Elena V. Chub, Vladimir A. Ternovoi, and Galina V. Kochneva. "Prevalence and molecular genetic characteristics of parenteral hepatitis B, C and D viruses in HIV positive persons in the Novosibirsk region." Problems of Virology 67, no. 5 (2022): 423–38. http://dx.doi.org/10.36233/0507-4088-133.

Full text

Abstract:

Introduction. Parenteral viral hepatitis (B, C, D) and HIV share modes of transmission and risk groups, in which the probability of infection with two or more of these viruses simultaneously is increased. Mutual worsening of the course of viral infections is important issue that occurs when HIV positive patients are coinfected with parenteral viral hepatitis. The aim of the study was to determine the prevalence of HCV, HBV and HDV in HIV positive patients in the Novosibirsk region and to give molecular genetic characteristics of their isolates. Materials and methods. Total 185 bloo

APA, Harvard, Vancouver, ISO, and other styles

3

Boston, Naomi S., and Judianne C. Slish. "Management of HIV Infection in Persons Co-infected With Hepatitis." Journal of Pharmacy Practice 18, no. 4 (2005): 295–309. http://dx.doi.org/10.1177/0897190005278509.

Full text

Abstract:

Co-infection with hepatitis C virus (HCV) and/or hepatitis B virus (HBV) is becoming a rampant disparity in HIV-infected patients. The advent of antiretroviral therapy has led to agents that are effective for suppression of both HIV and HBV; however, this can not be extrapolated to patients who are coinfected with HCV. Treatment of HCV disease is often strenuous and can lead to untoward adverse effects. Co-infection with HIV often leads to higher rates of cirrhosis and liver failure in patients with HBV or HCV, compromising antiretroviral treatment in this patient population due to the hepatot

APA, Harvard, Vancouver, ISO, and other styles

4

PRUSSING, C., C. CHAN, J. PINCHOFF, et al. "HIV and viral hepatitis co-infection in New York City, 2000–2010: prevalence and case characteristics." Epidemiology and Infection 143, no. 7 (2014): 1408–16. http://dx.doi.org/10.1017/s0950268814002209.

Full text

Abstract:

SUMMARYUsing surveillance data, we describe the prevalence and characteristics of individuals in New York City (NYC) co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) and/or hepatitis C virus (HCV). Surveillance databases including persons reported to the NYC Department of Health and Mental Hygiene with HIV, HBV, and HCV by 31 December 2010 and not known to be dead as of 1 January 2000, were matched with 2000–2011 vital statistics mortality data. Of 140 606 persons reported with HIV, 4% were co-infected with HBV only, 15% were co-infected with HCV only, and 1% wer

APA, Harvard, Vancouver, ISO, and other styles

5

Dr., Iqra Fayyaz Dr. Atifa Anzar Dr. Maryam Jamil. "ANALYSIS OF TREATMENT OF HEPATITIS C VIRUS IN HIV/HCV CO-INFECTION." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 05, no. 11 (2018): 12597–600. https://doi.org/10.5281/zenodo.1491764.

Full text

Abstract:

<strong><em>Introduction: </em></strong><em>Hepatitis C is an RNA flavivirus that infects 4 million people in the United States making up approximately 1.8% of the population, and 150-200 million worldwide. In persons with HIV, its prevalence is estimated to be approximately 50%. <strong>Aims and objectives: </strong>The basic aim of the study is to find the treatment of Hepatitis C Virus in HIV/HCV co-infection in Pakistan. <strong>Material and methods: </strong>This study was conducted at hospitals of Attock and Rawalpindi during Jan 2018 to July 2018. This study was done to find the treatme

APA, Harvard, Vancouver, ISO, and other styles

6

Anufrieva, E. V., E. N. Serikova, Yu V. Ostankova, et al. "The structure of some blood-borne infections distribution among persons from penitentiary institutions the markers." HIV Infection and Immunosuppressive Disorders 15, no. 3 (2023): 95–104. http://dx.doi.org/10.22328/2077-9828-2023-15-3-95-104.

Full text

Abstract:

The aim of the study was to assess the occurrence of serological and molecular genetic markers of HIV infection, viral hepatitis B and C among persons in pre-trial detention.Materials and methods. The material of the study identified 138 samples of blood sequences obtained from men in the pretrial detention center in St. Petersburg. Patients were examined by ELISA for the presence of serological markers of HIV infection (Ag/Ab HIV), HBV (HBsAg, antiHBs IgG, anti-HBcore IgG) and HCV (anti-HCV IgG). Determination of HIV and HCV RNA, as well as HBV DNA by PCR with hybridization-fluorescence detec

APA, Harvard, Vancouver, ISO, and other styles

7

Annison, Lawrence, Henry Hackman, Paulina Franklin Eshun, Sharon Annison, Peter Forson, and Samuel Antwi-Baffour. "Seroprevalence and effect of HBV and HCV co-infections on the immuno-virologic responses of adult HIV-infected persons on anti-retroviral therapy." PLOS ONE 17, no. 11 (2022): e0278037. http://dx.doi.org/10.1371/journal.pone.0278037.

Full text

Abstract:

Chronic hepatitis negatively affects persons living with HIV. While varying in their transmission efficiency, HIV, HBV, and HCV have shared routes of transmission. Available data suggest widely variable rates of HBV and HCV infections in HIV-infected populations across sub-Saharan Africa. With prolonged survival rates due to increased accessibility to antiretroviral drugs, HBV and HCV have the potential to complicate the prognosis of HIV co-infected patients by contributing significantly to continued morbidity and mortality. The study sought to determine the seroprevalence of HIV/HBV and HIV/H

APA, Harvard, Vancouver, ISO, and other styles

8

Konkle, Barbara A., Lehida Melendez-Morales, Liliana Preiss, et al. "Correlates of Spontaneous Clearance of Hepatitis C Virus among HIV-Infected Persons with Hemophilia." Blood 108, no. 11 (2006): 1265. http://dx.doi.org/10.1182/blood.v108.11.1265.1265.

Full text

Abstract:

Abstract Up to the late 1980s, hepatitis C virus (HCV) infected the majority of people with hemophilia (PWH) in the United States (US), via contaminated plasma clotting factor therapy. Approximately two-thirds of the HCV-infected PWH in the US also were infected with human immunodeficiency virus (HIV). The Second Multicenter Hemophilia Cohort Study (MHCS-II) investigated complications of HCV and HIV infections in people with hemophilia. From 2001 - 2005, data and specimens were collected from 2561 anti-HCV positive participants, including 763 who were co-infected with HIV. These data were anal

APA, Harvard, Vancouver, ISO, and other styles

9

Ostankova, Yu V., A. V. Semenov, E. B. Zueva, et al. "Prevalence of hepatitis B and D viruses in HIV-infected persons in the Socialist Republic of Vietnam." HIV Infection and Immunosuppressive Disorders 14, no. 1 (2022): 46–58. http://dx.doi.org/10.22328/2077-9828-2022-14-1-46-58.

Full text

Abstract:

The aim of this study was to estimate the prevalence of hepatitis B and D viruses among HIV-infected residents of South Vietnam.Materials and methods. The study material was represented by 316 blood serum samples collected from HIV-infected residents of the Socialist Republic of Vietnam taking antiretroviral therapy. The subjects were examined for the presence of HBV markers with a qualitative detection of HBsAg, HBs IgG, HBcore IgG, anti-HDV, DNA HBV, and RNA HDV. HBV and HDV complete genomes nucleotide sequences were obtained for 23 samples from HIV+HBV+HDV co-infected patients. Amplificatio

APA, Harvard, Vancouver, ISO, and other styles

10

Basimane-Bisimwa, Parvine, Giscard Wilfried Koyaweda, Edgarthe Ngaïganam, et al. "Seroprevalence and molecular characterization of viral hepatitis and HIV co-infection in the Central African Republic." PLOS ONE 19, no. 5 (2024): e0291155. http://dx.doi.org/10.1371/journal.pone.0291155.

Full text

Abstract:

Background The Central African Republic (CAR) is one of the countries with the highest prevalence of viral hepatitis infection in the world. Coinfection with HIV increases the morbidity and mortality beyond that of mono-infection with either hepatitis or HIV. The present study describes the geographic distribution of viral hepatitis infections and molecular characterization of these viruses in the CAR. Methodology Out of 12,599 persons enrolled during the fourth Multiple Indicator Cluster Survey of 2010 in the CAR, 10,621 Dried Blood Spot (DBS) samples were obtained and stored at -20°C. Of the

APA, Harvard, Vancouver, ISO, and other styles

11

Pramukti, S.Kp., MsC, Iqbal, Kusman Ibrahim, Mamat Lukman, Hasniatisari Harun, Andri Nugraha, and Chung-Ying Lin. "Estimating the 10-year fracture risk among persons with HIV and person without HIV: A comparative study." Jurnal Keperawatan Padjadjaran 13, no. 1 (2025): 59–65. https://doi.org/10.24198/jkp.v13i1.2715.

Full text

Abstract:

Background: The risk of osteoporotic fracture among persons with HIV was higher than the persons without HIV. Traditional factors are also found as the risk factor affecting fracture risk among persons with HIV and general population. Predicting the fracture risk among the high-risk group is important to develop a comprehensive fracture prevention program. Purpose: This study aimed to compare the estimation of the 10-year fracture risk between persons with HIV and persons without HIV using the FRAX™ algorithm. Methods: This study recruited 245 participants from August to November 2023, while 2

APA, Harvard, Vancouver, ISO, and other styles

12

BUREK, V., J. HORVAT, K. BUTORAC, and R. MIKULIĆ. "Viral hepatitis B, C and HIV infection in Croatian prisons." Epidemiology and Infection 138, no. 11 (2010): 1610–20. http://dx.doi.org/10.1017/s0950268810000476.

Full text

Abstract:

SUMMARYIncarcerated persons comprise about 0·4% of the Croatian population, of whom 25–30% misuse drugs. We attempted to determine the structure of the prison population, prevalence of HBV, HCV, HIV markers, co-infections with HBV, HCV and HIV and acute HBV, HCV and HIV infection. In total, 25·9% of prisoners were positive for some markers for viral hepatitis (HBV 11·3%, HCV 8·3%, HBV/HCV 6·3%). Prevalence of HBV infection in intravenous drug users (IDUs) was 26·2% (highly promiscuous group 20·4%, individuals with psychiatric diseases and personality disorders 16·0%). HCV infection in IDUs was

APA, Harvard, Vancouver, ISO, and other styles

13

Sizemore, Lindsey, Mary-Margaret Fill, Samantha A. Mathieson, et al. "Using an Established Outbreak Response Plan and Molecular Epidemiology Methods in an HIV Transmission Cluster Investigation, Tennessee, January–June 2017." Public Health Reports 135, no. 3 (2020): 329–33. http://dx.doi.org/10.1177/0033354920915445.

Full text

Abstract:

Introduction In April 2017, the Tennessee Department of Health (TDH) was notified of an increase in the number of persons newly diagnosed with HIV in eastern Tennessee in the same month. Two were identified as persons with a history of injection drug use (IDU) and named each other as syringe-sharing partners, prompting an investigation into a possible HIV cluster among persons with a history of IDU. Materials and Methods TDH and public health staff members in eastern Tennessee collaborated to implement procedures outlined in TDH’s HIV/hepatitis C virus (HCV) Outbreak Response Plan, including c

APA, Harvard, Vancouver, ISO, and other styles

14

Sun, Bing, Linda Abadjian, Alexander Monto, Heather Freasier, and Lynn Pulliam. "Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms." Journal of Infectious Diseases 222, no. 3 (2020): 396–406. http://dx.doi.org/10.1093/infdis/jiaa109.

Full text

Abstract:

Abstract Background Chronic inflammation in human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfection increases cognitive impairment. With newer, direct-acting antiviral therapies for HCV, our objective was to determine whether chronic inflammation would be decreased and cognition improved with HCV sustained viral response (SVR) in coinfection. Methods We studied 4 groups longitudinally: 7 HCV-monoinfected and 12 HIV/HCV-coinfected persons before and after treatment for HCV, 12 HIV-monoinfected persons, and 9 healthy controls. We measured monocyte activation and gene expression, m

APA, Harvard, Vancouver, ISO, and other styles

15

Lauer, Georg M., Tam N. Nguyen, Cheryl L. Day, et al. "Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses." Journal of Virology 76, no. 6 (2002): 2817–26. http://dx.doi.org/10.1128/jvi.76.6.2817-2826.2002.

Full text

Abstract:

ABSTRACT Both human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) lead to chronic infection in a high percentage of persons, and an expanding epidemic of HIV-1-HCV coinfection has recently been identified. These individuals provide an opportunity for simultaneous assessment of immune responses to two viral infections associated with chronic plasma viremia. In this study we analyzed the breadth and magnitude of the CD8+- and CD4+-T-lymphocyte responses in 22 individuals infected with both HIV-1 and HCV. A CD8+-T-lymphocyte response against HIV-1 was readily detected in all s

APA, Harvard, Vancouver, ISO, and other styles

16

Tumpa, Shanjida Islam, and Abdullah Al Mamun. "HIV/HBV Co-infection - A Global Challenge." Bangladesh Journal of Medical Science 14, no. 4 (2015): 316–22. http://dx.doi.org/10.3329/bjms.v14i4.19392.

Full text

Abstract:

With prevalence worldwide approximately 10% of the HIV-infected population is infected with hepatitis B. In persons with HBV and HIV co-infection, HBV-related liver disease progresses more rapidly than in those with HBV mono-infection leading to increased rates of persistent infection, higher HBV DNA levels, increased cirrhosis and liver-related mortality, increased risk of hepatocellular carcinoma, and decreased efficacy of anti-HBV therapy. Furthermore, HIV-infected patients co-infected with HBV have an increased risk for antiretroviral therapy-related hepatotoxicity. The management of hepat

APA, Harvard, Vancouver, ISO, and other styles

17

Kim, Arthur Y., Georg M. Lauer, Kei Ouchi, et al. "The magnitude and breadth of hepatitis C virus–specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1." Blood 105, no. 3 (2005): 1170–78. http://dx.doi.org/10.1182/blood-2004-06-2336.

Full text

Abstract:

AbstractCD8+ T-cell responses are an essential antiviral host defense in persistent viral infections, and their sustained effectiveness is thought to be critically dependent on CD4+ T-helper cells. To determine the relationship between HIV-1–induced CD4+ T-cell depletion and hepatitis C virus (HCV)–specific CD8+ T-cell responses during viral persistence, we studied 103 persons positive for HCV, 74 coinfected with HIV-1. CD8+ T-cell responses to the entire HCV polyprotein were determined by using an interferon-γ enzyme-linked immunospot (ELISpot) assay. Although HIV-1 infection by itself was no

APA, Harvard, Vancouver, ISO, and other styles

18

Ondondo, Raphael O., Jacques Muthusi, Violet Oramisi, et al. "Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018." PLOS ONE 19, no. 11 (2024): e0310923. http://dx.doi.org/10.1371/journal.pone.0310923.

Full text

Abstract:

Background Sub-Saharan Africa region bears the highest chronic hepatitis B virus (HBV) infection burden worldwide. National estimates of HBV burden are necessary for a viral hepatitis program planning. This study estimated the national prevalence of HBV infection in Kenya among people aged 15–64 years. Methods Of 27,745 participants age 15–64 years in the Kenya Population-based HIV Impact Assessment (KENPHIA) 2018 household survey, we analyzed data for all persons living with HIV (PLHIV; n = 1,521) and a random sample of HIV-negative persons (n = 1,551), totaling to 3,072 participants. We test

APA, Harvard, Vancouver, ISO, and other styles

19

Meyer, Alexander, Sanjay Dandamudi, Chad Achenbach, Donald Lloyd-Jones, and Matthew Feinstein. "Ventricular Ectopy and Arrhythmia Characteristics for Persons Living with HIV and Uninfected Controls." Journal of the International Association of Providers of AIDS Care (JIAPAC) 18 (January 1, 2019): 232595821985212. http://dx.doi.org/10.1177/2325958219852123.

Full text

Abstract:

Background: Persons with HIV have elevated risk for cardiovascular disease, but little is known about the risk of ventricular ectopy and ventricular tachycardia (VE/VT) for HIV-infected (HIV+) persons. Methods: We evaluated the presence and anatomic origin of VE/VT for HIV+ persons and controls by screening a cohort using International Classification of Diseases codes and adjudicating positive screens by chart review. We sought to evaluate (1) presence of VE/VT and (2) likely anatomic origin of the VE/VT based on electrocardiogram. Results: There was no significant difference in the prevalence

APA, Harvard, Vancouver, ISO, and other styles

20

Chew, Kara W., Chia-Ying Liu, Bharath Ambale-Venkatesh, et al. "Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons." Journal of International Medical Research 45, no. 6 (2017): 1693–707. http://dx.doi.org/10.1177/0300060517708919.

Full text

Abstract:

Objective The contribution of hepatitis C virus (HCV) infection to the risk of heart failure in human immunodeficiency virus (HIV)-coinfected persons is unknown. The objective was to characterize cardiac function and morphology in HIV-treated coinfected persons. Methods In a cross-sectional study, HIV-infected patients virologically suppressed on antiretroviral therapy without known cardiovascular disease or diabetes mellitus underwent cardiac magnetic resonance imaging and spectroscopy for measures of cardiac function, myocardial fibrosis, and steatosis. Results The study included 18 male pat

APA, Harvard, Vancouver, ISO, and other styles

21

Speight, Carly C., Bobbi J. Stoner, George A. Guthrie, et al. "972. Infection and Overdose Prevention for Persons with Injection Drug Use-Related Infections: Evaluation of an Inpatient Quality Improvement Program." Open Forum Infectious Diseases 7, Supplement_1 (2020): S515. http://dx.doi.org/10.1093/ofid/ofaa439.1158.

Full text

Abstract:

Abstract Background Hospitalizations for injection drug use-related infections (IDU-I) are increasing in North Carolina and nationally. Many IDU-I, such as endocarditis, bone, joint, and spine infections, require long antimicrobial courses and extended inpatient stays. These hospitalizations are opportunities to engage patients in overdose and infection prevention. Methods A quality improvement (QI) program was piloted for inpatients with IDU-I. Eligible patients admitted to the inpatient pulmonary or infectious disease teams from 11/2019 to 01/2020 were referred to the QI team if they reporte

APA, Harvard, Vancouver, ISO, and other styles

22

Hoenigl, Martin, Chris Coyne, Jill Blumenthal, Gary Vilke, and Susan Little. "1274. Universal HIV and HCV Screening in San Diego Emergency Departments: Implications for Other Settings With a High Density of Free of Charge HIV Screening Programs." Open Forum Infectious Diseases 5, suppl_1 (2018): S388. http://dx.doi.org/10.1093/ofid/ofy210.1107.

Full text

Abstract:

Abstract Background While HIV and HCV testing targeted to high-risk groups results in substantially higher proportions of HIV diagnoses, universal HIV and HCV screening in emergency department (ED) settings is expected to reach populations who do not perceive themselves to be at risk or are otherwise less likely to participate in HIV and HCV testing. As a consequence the CDC recommends routine HIV screening for persons 13–64 years of age, and routine HCV screening for the birth cohort (born between 1945–1965). The objective of this analysis was to evaluate the yield of universal opt-out HIV an

APA, Harvard, Vancouver, ISO, and other styles

23

ADEGENE, Martha Odanwu DANJUMA Ndonima Uhwe MARLINE O. Oluchi &. ELOH Blessing Igele. "HEALTH COMMUNICATION APPROACHES IN REDUCING HESITANT DISCLOSURE OF HIV/AIDS STATUS AMONG PLWHIV IN AKWANGA L.G.A OF NASARAWA STATE." IMSU Journal of Communication Studies 9, no. 1 (2025): 111–23. https://doi.org/10.5281/zenodo.15240667.

Full text

Abstract:

This study, Health Communication Approaches in Reducing Hesitant Disclosure of HIV/AIDS among affected Persons in Akwanga Local Government Area of Nasarawa State was guided by the following objectives; to examine the effects of health communication on behavioural change among Persons Living with HIV/AIDS in Akwanga, to find out how health communication approach has reduced hesitant disclosure among Persons Living with HIV/AIDS in Akwanga and to determine the extent which health communication approach has helped in reducing hesitant disclosure among Persons Living with HIV/AIDS in Akwanga. The

APA, Harvard, Vancouver, ISO, and other styles

24

Anh, Le Hieu Thuy, and Suchada Thaweesit. "FACTORS ASSOCIATED WITH HEPATITIS B AND C CO-INFECTION AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS IN VIETNAM." Belitung Nursing Journal 5, no. 4 (2019): 147–54. http://dx.doi.org/10.33546/bnj.813.

Full text

Abstract:

Background: Human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) are the leading causes of death from infectious diseases. Because of sharing same transmission routes, the co-infection of HIV with HBV or HCV is common. And the co-infections make HIV infected persons have higher morbidity and mortality than those who infected only with HIV. This study aims to investigate factors that may have influence on the co-infections of HBV or HCV among HIV positive individuals.Objective: The goals of this study were to identify factors associated with the co-infection o

APA, Harvard, Vancouver, ISO, and other styles

25

Butt, Adeel A., Peng Yan, Samia Aslam, et al. "285. Fibrosis Progression and Clinical Outcomes in HCV/HBV Coinfected Persons in the ERCHIVES Cohort." Open Forum Infectious Diseases 6, Supplement_2 (2019): S155—S156. http://dx.doi.org/10.1093/ofid/ofz360.360.

Full text

Abstract:

Abstract Background Progression of liver disease and clinical outcomes in HCV/HBV coinfected persons and how they differ from HCV monoinfected persons and HCV infected persons with resolved HBV infection are not well characterized. We compared incidence of cirrhosis, hepatic decompensation and overall mortality in these three groups. Methods Using the Electronically Retrieved Cohort of HCV-infected Veterans (ERCHIVES), we identified those with HCV infection only, HCV/HBV coinfection (HbsAg or HBV DNA or both positive) or HCV with resolved HBV (HbcAb+ in absence of HbsAg or HBV DNA positivity).

APA, Harvard, Vancouver, ISO, and other styles

26

Sergevnin, V. I., and O. V. Tukacheva. "Manifestations of epidemic process of tuberculosis among HIV-infected patients and dependence of infection frequency on immunodeficiency level and HIV viral load." Perm Medical Journal 39, no. 1 (2022): 85–93. http://dx.doi.org/10.17816/pmj39185-93.

Full text

Abstract:

Objective. To assess the manifestations of the epidemic process of tuberculosis (TB) in HIV-infected persons and the frequency of infection depending on the level of immunodeficiency and viral load. Materials and methods. The epidemiological manifestations of TB incidence among HIV-infected and HIV-negative population of the Perm Region for 20142019 were studied. The frequency of TB in HIV-infected patients was determined depending on the level of immunodeficiency (96 patients) and viral load (61 patients). Results. On average, the incidence of TB among HIV-infected persons was by

APA, Harvard, Vancouver, ISO, and other styles

27

International, Journal of Medical Science and Advanced Clinical Research (IJMACR). "Study of Markers of Hepatitis B Virus (HBV) Infection among HIV Infected Patients and Its Co-Relation with CD4 Counts in A Tertiary Care Hospital." International Journal of Medical Science and Advanced Clinical Research (IJMACR) 8, no. 1 (2025): 12–18. https://doi.org/10.5281/zenodo.15227932.

Full text

Abstract:

<strong>Abstract</strong> <strong>Introduction: </strong>Coinfection with Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) is common worldwide.  Although spontaneous clearance of HBV acquired in adulthood occurs in >90% of immunocompetent individuals, HIV-infected individuals are half as likely as HIV uninfected persons to spontaneously clear HBV. Chronic HBV infection occurs in 5-10% of HIV/HBV coinfected individuals. <strong>Objectives</strong> 1.      To study Prevalence of HBV among HIV infected patients 2.      To stu

APA, Harvard, Vancouver, ISO, and other styles

28

Breskin, Alexander, Daniel Westreich, Christopher B. Hurt, et al. "The Effects of Hepatitis C Treatment Eligibility Criteria on All-cause Mortality Among People With Human Immunodeficiency Virus." Clinical Infectious Diseases 69, no. 9 (2019): 1613–20. http://dx.doi.org/10.1093/cid/ciz008.

Full text

Abstract:

Abstract Background The cost of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) prompted many payers to restrict treatment to patients who met non–evidence-based criteria. These restrictions have implications for survival of people with HCV, especially for people with human immunodeficiency virus (HIV)/HCV coinfection who are at high risk for liver disease progression. The goal of this work was to estimate the effects of DAA access policies on 10-year all-cause mortality among people with HIV. Methods The study population included 3056 adults with HIV in the Women’s Interagency HIV

APA, Harvard, Vancouver, ISO, and other styles

29

Sdegbindin, Rafiou, Gatien Adjimon Gbènakpon Lokossou, Paulin Kpodji, et al. "Innate immune cells and T CD4 cells profile during hepatitis B among HIV co-infection Beninese." International Journal of Research in Medical Sciences 10, no. 12 (2022): 2737. http://dx.doi.org/10.18203/2320-6012.ijrms20223074.

Full text

Abstract:

Background: Worldwide, human immunodeficiency virus (HIV) infection remains a real public health. Hepatitis B virus (HBV) and HIV have the same routes of transmission and shared risk factors and epidemiology similarities. The purpose of this study was to assess the impact of HBV and HIV co-infection on T CD4 cells and innate immune cells.Methods: A cross-sectional and descriptive study was carried among 260 persons living with HIV (PLHIV) admitted and supported with antiviral tri therapy at the national reference center for research and Care of HIV infected person (NRCRC) of the national hospi

APA, Harvard, Vancouver, ISO, and other styles

30

Fleisher, Ilan, Alexander G. Geboy, Whitney Nichols, et al. "HIV testing in patients who are HCV positive: Compliance with CDC guidelines in a large healthcare system." PLOS ONE 16, no. 6 (2021): e0252412. http://dx.doi.org/10.1371/journal.pone.0252412.

Full text

Abstract:

Background There are approximately 300,000 people in the United States who are co-infected with HIV and HCV. Several organizations recommend that individuals who are HCV infected, as well as persons over the age of 13, should be HIV tested. Comorbidities associated with HCV can be reduced with early identification of HIV. Our objective was to determine whether providers routinely followed HIV testing guidelines for patients who tested HCV positive (HCV+). Methods A retrospective chart review was conducted of all patients in primary care at an academic health system from 7/2015–3/2017 who teste

APA, Harvard, Vancouver, ISO, and other styles

31

Bar, Nir, Noa Bensoussan, Liane Rabinowich, et al. "Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus." International Journal of Environmental Research and Public Health 19, no. 22 (2022): 15237. http://dx.doi.org/10.3390/ijerph192215237.

Full text

Abstract:

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are often co-transmitted. Viral coinfection results in worse outcomes. Persons who inject drugs (PWIDs) face barriers to medical treatment, but HCV treatment is indicated and effective even with ongoing active drug use. We aimed to assess access to HCV care and treatment results in patients coinfected with HIV-HCV. This is a real-world retrospective single-center study of patients followed in the HIV clinic between 2002 and 2018. Linkage to care was defined as achieving care cascade steps: (1) hepatology clinic visit, (2) receiving

APA, Harvard, Vancouver, ISO, and other styles

32

J.A., Nazarova, Bahadirkhanov M.M., and Zukhritdinova D.G. "STRUCTURE OF ACUTE INFLAMMATORY DISEASES OF THE BRAIN DEPENDING ON HIV INFECTION." JOURNAL OF UNIVERSAL SCIENCE RESEARCH 1, no. 4 (2023): 102–6. https://doi.org/10.5281/zenodo.7857118.

Full text

Abstract:

Between 2014 and 2019 On the basis of RRCEMMP and the Research Institute of Virology of the Ministry of Health of the Republic of Uzbekistan, a clinical and laboratory study of 419 patients was conducted to study the structure of acute inflammatory diseases of the brain depending on the HIV status of patients. It was determined that among the examined patients with OVE, almost every 2nd patient with OVE had an HIV positive status (49.1%). Among these patients, women (62.5%) and young patients (50.0%) predominated. In the group of HIV-negative patients with high reliability, persons with serous

APA, Harvard, Vancouver, ISO, and other styles

33

Balde, T. A. L., Yu V. Ostankova, S. Boumbaly, et al. "Prevalence of Markers of Certain Blood-Borne Viral Infections in Pregnant Women and Their Partners in the Republic of Guinea." Problems of Particularly Dangerous Infections, no. 3 (September 30, 2023): 51–58. http://dx.doi.org/10.21055/0370-1069-2023-3-51-58.

Full text

Abstract:

The aim of the work was to estimate the prevalence of HIV, HBV and HCV markers among pregnant women and their male partners in the Republic of Guinea.Materials and methods. The material of the study was blood plasma samples from 140 pregnant women living in Kindia prefecture and N’Zerekore prefecture, as well as 60 male partners who reported sexual contact with HIV-infected persons. The samples were examined for the presence of serological (HBsAg, HBeAg, antibodies anti-HBs IgG, anti-HBcore IgG, anti-HBe IgG, anti-HCV IgG, Ag/Ab-HIV) and molecular (HBV DNA, HCV RNA, HIV RNA) markers.Results an

APA, Harvard, Vancouver, ISO, and other styles

34

Fan, Zheng, Xiao-Li Huang, Pawel Kalinski, Stephen Young, and Charles R. Rinaldo. "Dendritic Cell Function during Chronic Hepatitis C Virus and Human Immunodeficiency Virus Type 1 Infection." Clinical and Vaccine Immunology 14, no. 9 (2007): 1127–37. http://dx.doi.org/10.1128/cvi.00141-07.

Full text

Abstract:

ABSTRACT Hepatitis C virus (HCV) infection can persist despite HCV-specific T-cell immunity and can have a more aggressive course in persons coinfected with human immunodeficiency virus type 1 (HIV-1). Defects in antigen-presenting, myeloid dendritic cells (DCs) could underlie this T-cell dysfunction. Here we show that monocyte-derived DCs from persons with chronic HCV infection, with or without HIV-1 coinfection, being treated with combination antiretroviral therapy produced lower levels of interleukin 12 (IL-12) p70 in response to CD40 ligand (CD40L), whereas the expression of DC surface act

APA, Harvard, Vancouver, ISO, and other styles

35

Chkhartishvili, Nikoloz, Natalia Bolokadze, Nino Rukhadze, et al. "Impact of hepatitis C virus antibody positivity on mortality and causes of death in people living with HIV in Georgia." International Journal of STD & AIDS 30, no. 12 (2019): 1185–93. http://dx.doi.org/10.1177/0956462419866055.

Full text

Abstract:

Hepatitis C co-infection in people living with HIV (PLWH) is common in Georgia. Antiretroviral therapy (ART) is widely available in the country since 2004, and from 2011, patients have unlimited access to hepatitis C virus (HCV) treatment. A retrospective nationwide cohort study included adult PLWH diagnosed between 2004–2016, who were followed up until 31 December 2017. Predictors of mortality were assessed in Cox proportional hazards regression model. A total of 4560 persons contributed 22,322 person-years (PY) of follow-up, including 2058 (45.1%, 10,676 PY) anti-HCV+ patients. After the med

APA, Harvard, Vancouver, ISO, and other styles

36

Tzou, Philip L., Diane Descamps, Soo-Yon Rhee, et al. "Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2." Journal of Infectious Diseases 221, no. 12 (2020): 1962–72. http://dx.doi.org/10.1093/infdis/jiaa026.

Full text

Abstract:

Abstract Background HIV-1 and HIV-2 differ in their antiretroviral (ARV) susceptibilities and drug resistance mutations (DRMs). Methods We analyzed published HIV-2 pol sequences to identify HIV-2 treatment-selected mutations (TSMs). Mutation prevalences were determined by HIV-2 group and ARV status. Nonpolymorphic mutations were those in &lt;1% of ARV-naive persons. TSMs were those associated with ARV therapy after multiple comparisons adjustment. Results We analyzed protease (PR) sequences from 483 PR inhibitor (PI)-naive and 232 PI-treated persons; RT sequences from 333 nucleoside RT inh

APA, Harvard, Vancouver, ISO, and other styles

37

Di Carlofelice, M., A. Everitt, D. Muir, and A. Winston. "Cerebrospinal fluid HIV RNA in persons living with HIV." HIV Medicine 19, no. 5 (2018): 365–68. http://dx.doi.org/10.1111/hiv.12594.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Anandan, Navaraj, Brent Braveman, Gary Kielhofner, and Kirsty Forsyth. "Impairments and perceived competence in persons living with HIV/AIDS." WORK: A Journal of Prevention, Assessment & Rehabilitation 27, no. 3 (2006): 255–66. https://doi.org/10.3233/wor-2006-00568.

Full text

Abstract:

Medical advances have transformed HIV/AIDS from a short-term terminal illness to a long-term chronic condition. Consequently, the disability experience of persons with HIV illness has shifted from issues related to physical well-being to those concerning performance of daily life activities and wider community participation. These changes have necessitated rehabilitation interventions for persons with HIV/AIDS to focus on issues related to enabling participation in all spheres of everyday activities. However, limited information is available on the impairments prevalent in the emergent populat

APA, Harvard, Vancouver, ISO, and other styles

39

Agyemang, Elfriede, Clement Zeh, Irene Mukui, David Maman, and Andrea Kim. "HIV Transmission Rates and Factors Associated with Recent HIV Infection: Results from the Ndhiwa HIV Impact Assessment, South Nyanza, Kenya, 2012." Open Forum Infectious Diseases 4, suppl_1 (2017): S15. http://dx.doi.org/10.1093/ofid/ofx162.037.

Full text

Abstract:

Abstract Background Identifying populations with high HIV transmission rates is important for prevention and treatment strategies. Persons with recently acquired HIV infection are drivers of HIV transmission due to high levels of HIV viral load (VL). We assessed annual HIV transmission rates and factors associated with recent infection to inform targeted interventions in a hyperendemic region in Kenya. Methods The Ndhiwa HIV impact assessment was a population-based survey among persons aged 15–59 years living in South Nyanza, Kenya in 2012. Respondents were tested for HIV using rapid tests per

APA, Harvard, Vancouver, ISO, and other styles

40

Patel, Deesha, Weston O. Williams, Janet Heitgerd, Nicole Taylor-Aidoo, and Elizabeth A. DiNenno. "Estimating Gains in HIV Testing by Expanding HIV Screening at Routine Checkups." American Journal of Public Health 111, no. 8 (2021): 1530–33. http://dx.doi.org/10.2105/ajph.2021.306321.

Full text

Abstract:

Objectives. To estimate gains in the prevalence of individuals who had ever been tested for HIV overall and by subpopulations from increases in the percentage of persons who had a routine checkup and were tested. Methods. We used data from the 2019 Behavioral Risk Factor Surveillance System to determine the prevalence of individuals who were ever tested for HIV and the prevalence of missed opportunities for HIV testing among those never tested in the United States. We assessed the effect of absolute percentage increases in having ever been tested among those who had a past-year routine checkup

APA, Harvard, Vancouver, ISO, and other styles

41

Salia, Emmanuel, Yvonne Ayerki Nartey, Francis Tanam Djankpa, Faustina Pappoe, Samuel Victor Nuvor, and Dorcas Obiri-Yeboah. "Prevalence of occult hepatitis B infection among treatment-naive persons living with HIV in Ghana." PLOS ONE 19, no. 6 (2024): e0305862. http://dx.doi.org/10.1371/journal.pone.0305862.

Full text

Abstract:

Hepatitis B virus (HBV) constitutes a significant global health challenge, with more than 2 billion people infected globally and almost 291 million chronic cases. In Africa, coinfection of HBV with Human Immunodeficiency Virus (HIV) is high, yet the condition remains overlooked in many countries. While antiretroviral therapy (ART) has improved HIV survival, viral hepatitis continues to contribute to morbidity and mortality. Occult Hepatitis B infection (OBI), characterized by a low-level of HBV DNA in individuals with negative hepatitis B surface antigen (HBsAg), is an emerging concern among H

APA, Harvard, Vancouver, ISO, and other styles

42

Barry, Michael J., Wanda K. Nicholson, Michael Silverstein, et al. "Preexposure Prophylaxis to Prevent Acquisition of HIV." JAMA 330, no. 8 (2023): 736. http://dx.doi.org/10.1001/jama.2023.14461.

Full text

Abstract:

ImportanceAn estimated 1.2 million persons in the US currently have HIV, and more than 760 000 persons have died of complications related to HIV since the first cases were reported in 1981. Although treatable, HIV is not curable and has significant health consequences. Therefore, effective strategies to prevent HIV are an important public health and clinical priority.ObjectiveThe US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of preexposure prophylaxis with antiretroviral therapy for the prevention of HIV acquisition, and the diag

APA, Harvard, Vancouver, ISO, and other styles

43

Ang, Li Wei, Matthias Paul Han Sim Toh, Irving Charles Boudville, et al. "Epidemiological factors associated with the absence of previous HIV testing among HIV-positive persons in Singapore, 2012–2017." BMJ Open 11, no. 8 (2021): e050133. http://dx.doi.org/10.1136/bmjopen-2021-050133.

Full text

Abstract:

ObjectiveTo assess the temporal trend and identify risk factors associated with the absence of previous HIV testing prior to their diagnosis among HIV-positive persons in Singapore.Study designCross-sectional.Setting and participantsWe analysed data of HIV-positive persons infected via sexual transmission, who were notified to the National HIV Registry in 2012–2017.OutcomesEpidemiological factors associated with the absence of HIV testing prior to diagnosis were determined separately for two groups of HIV-positive persons: early and late stages of HIV infection at diagnosis.Results2188 HIV-pos

APA, Harvard, Vancouver, ISO, and other styles

44

Galletly, C. L., and J. Dickson-Gomez. "HIV seropositive status disclosure to prospective sex partners and criminal laws that require it: perspectives of persons living with HIV." International Journal of STD & AIDS 20, no. 9 (2009): 613–18. http://dx.doi.org/10.1258/ijsa.2008.008417.

Full text

Abstract:

Thirty-one HIV-positive persons living in Michigan took part in focus group discussions about Michigan's HIV disclosure law. Discussion themes included perceived responsibility to prevent infection, concern about unwanted secondary disclosure of HIV-positive status, fear of being falsely accused of violating Michigan's HIV disclosure law and perceived vulnerability of HIV-positive persons within the US legal system. Although participants strongly agreed with the ostensible purpose of Michigan's criminal HIV disclosure law, there was considerable concern about the negative impact of the law on

APA, Harvard, Vancouver, ISO, and other styles

45

Maritim, Charity, Leigh McClarty, Stella Leung, et al. "HIV treatment outcomes among newcomers living with HIV in Manitoba, Canada." Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 6, no. 2 (2021): 119–28. http://dx.doi.org/10.3138/jammi-2020-0042.

Full text

Abstract:

Background: Despite the overrepresentation of immigrants and refugees (newcomers) in the HIV epidemic in Canada, research on their HIV treatment outcomes is limited. This study addressed this knowledge gap by describing treatment outcomes of newcomers in comparison with Canadian-born persons living with HIV in Manitoba. Methods: Clinical data from 1986 to 2017 were obtained from a cohort of people living with HIV and receiving care from the Manitoba HIV Program. Retrospective cohort analysis of secondary data was completed using univariate and multivariate statistics to compare differences in

APA, Harvard, Vancouver, ISO, and other styles

46

Pinkney, Jodian, Divya Ahuja, Caroline Derrick, Shannon B. Faulkenberry, and Martin Durkin. "1291. Comparison of Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Screening Rates Before and After Implementation of a Quality Improvement (QI) Project Aimed at Incorporating Routine “Opt-Out” Testing at a Primary Care Resident Clinic in Columbia, SC." Open Forum Infectious Diseases 6, Supplement_2 (2019): S465—S466. http://dx.doi.org/10.1093/ofid/ofz360.1154.

Full text

Abstract:

Abstract Background Southern states account for the majority of new cases of Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) in the United States. Despite this, routine screening for these viruses in asymptomatic individuals remains low and patients often present with advanced disease. Methods We examined the screening rates for HIV and HCV before and after implementation of a Quality Improvement (QI) project aimed at routine “opt out” testing in asymptomatic individuals. The QI project was implemented at a single primary care clinic in February 2019 and will continue until Augu

APA, Harvard, Vancouver, ISO, and other styles

47

Fitzpatrick, Lisa K., Daveda Hudson, and Aurnell Dright. "Guidelines for Persons With HIV." Annals of Internal Medicine 157, no. 11 (2012): 832. http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Wood, Evan, and Julio S. G. Montaner. "Guidelines for Persons With HIV." Annals of Internal Medicine 157, no. 11 (2012): 832. http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Altice, Frederick L. "Guidelines for Persons With HIV." Annals of Internal Medicine 157, no. 11 (2012): 833. http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Gordin, Fred M., Mollie P. Roediger, Pierre-Marie Girard, et al. "Pneumonia in HIV-infected Persons." American Journal of Respiratory and Critical Care Medicine 178, no. 6 (2008): 630–36. http://dx.doi.org/10.1164/rccm.200804-617oc.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!